DCF — ROOSEVELT GENERAL HOSPITAL
Enterprise Value: $-32.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-32.2M
Enterprise Value
$-10.8M
PV of Cash Flows
$-21.4M
PV of Terminal Value
$-34.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $37.5M | $-1.7M | -5.0% | $-3.3M | $-3.0M |
| Year 2 | $38.7M | $-1.4M | -4.0% | $-3.0M | $-2.5M |
| Year 3 | $39.8M | $-1.0M | -3.0% | $-2.7M | $-2.0M |
| Year 4 | $41.0M | $-0.8M | -2.0% | $-2.6M | $-1.7M |
| Year 5 | $42.2M | $-0.7M | -2.0% | $-2.5M | $-1.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-32.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$36.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000548910446
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5